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Abstract
The reaction catalyzed by succinate-CoA ligase in the mitochondrial matrix yields a high-energy phosphate when operating 
towards hydrolysis of the thioester bond of succinyl-CoA, known as mitochondrial substrate-level phosphorylation (mSLP). 
The catabolism of several metabolites converge to succinyl-CoA but through different biochemical pathways. Among them, 
threonine, serine and methionine catabolize to succinyl-CoA through the common intermediate, 2-ketobutyrate. During 
the course of this pathway 2-ketobutyrate will become succinyl-CoA through propionyl-CoA catabolism, obligatorily pass-
ing through an ATP-consuming step substantiated by propionyl-CoA carboxylase. Here, by recording the directionality 
of the adenine nucleotide translocase while measuring membrane potential we tested the hypothesis that catabolism of 
2-ketobutyrate negates mSLP due to the ATP-consuming propionyl-CoA carboxylase step in rotenone-treated, isolated 
mouse liver and brain mitochondria. 2-Ketobutyrate produced a less negative membrane potential compared to NADH or 
 FADH2-linked substrates, which was sensitive to inhibition by rotenone, atpenin and arsenate, implying the involvement of 
complex I, complex II and a dehydrogenase—most likely branched chain keto-acid dehydrogenase, respectively. Co-addition 
of 2-ketobutyrate with NADH- or  FADH2-linked substrates yielded no greater membrane potential than in the presence of 
substrates alone. However, in the presence of NADH-linked substrates, 2-ketobutyrate prevented mSLP in a dose-dependent 
manner. Our results imply that despite that 2-ketobutyrate leads to succinyl-CoA formation, obligatory metabolism through 
propionyl-CoA carboxylase associated with ATP expenditure abolishes mSLP. The provision of metabolites converging to 
2-ketobutyrate may be a useful way for manipulating mSLP without using pharmacological or genetic tools.
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Introduction
Mitochondrial substrate-level phosphorylation (mSLP) 
mediated by succinate-CoA ligase is a reversible process 
by which ATP (or GTP, depending on subunit composition 
of the enzyme [1, 2]) can be generated in the absence of 
oxidative phosphorylation. This is feasible due to the high 
energy stored in the thioester bond of succinyl-CoA. A num-
ber of metabolites converge towards succinyl-CoA; how-
ever, with the exception of those catabolizing first through 
α-ketoglutarate, all others will obligatorily pass through 
biochemical pathways encompassing at least one ATP-
expenditure step, see Fig. 1. Catabolism of threonine and 
methionine converge to 2-ketobutyrate (2-KB, also known as 
α-ketobutyrate, 2-oxobutyrate, 2-oxobutanoate, CAS Regis-
try Number: 600-18-0), prior to entering into the propionate 
catabolic pathway towards succinyl-CoA. Serine joins the 
methionine catabolic pathway by combining with homocyst-
eine forming cystathionine which forms 2-KB, cysteine and 
ammonia by cystathionine gamma-lyase. All of the reactions 
leading to 2-KB formation occur outside mitochondria, thus 
2-KB entry into the matrix for subsequent catabolism is war-
ranted. Mindful that in the absence of oxidative phosphoryl-
ation the directionality of the adenine nucleotide translocase 
(ANT) and the reaction catalyzed by succinate-CoA ligase 
are in directional synchrony [3] linked by the matrix [ATP]/
[ADP] [4, 5], we hypothesized that metabolites converging 
to succinyl-CoA through ATP-consuming pathways would 
negate mSLP, and this would be reflected in the reversal of 
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ANT when the electron transport chain is inhibited. Part of 
this work has been published before in abstract form [6].
Materials and Methods
Animals
Mice were of mixed 129 Sv and C57Bl/6 background. The 
animals used in our study were of either sex and between 2 
and 6 months of age. Data obtained from liver mitochondria 
of mice of a particular gender or age (2, 4 or 6 months) 
did not yield any qualitative differences, thus all data were 
pooled. Mice were housed in a room maintained at 20–22 °C 
on a 12-h light–dark cycle with food and water available 
ad libitum. All experiments were approved by the Animal 
Care and Use Committee of the Semmelweis University 
(Egyetemi Állatkísérleti Bizottság).
Isolation of Mitochondria
Liver and brain mitochondria were isolated as described in 
Ref. [7]. Protein concentration was determined using the 
bicinchoninic acid assay, and calibrated using bovine serum 
standards [8] using a Tecan Infinite® 200 PRO series plate 
reader (Tecan Deutschland GmbH, Crailsheim, Germany).
Determination of Membrane Potential in Isolated 
Mitochondria
ΔΨm of isolated mitochondria (0.5 mg for mouse liver 
and 0.25 mg for brain per 2 ml of medium) was estimated 
fluorimetrically with safranine O [9], acknowledging the 
considerations elaborated in [10, 11] regarding inhibition 
of respiration as well as unspecific binding of safranine. 
Fluorescence was recorded in a Hitachi F-7000 spectro-
fluorimeter (Hitachi High Technologies, Maidenhead, UK) 
at a 5-Hz acquisition rate, using 495- and 585-nm excitation 
and emission wavelengths, respectively. Experiments were 
performed at 37 °C.
Reagents: Standard laboratory chemicals and 2-ketobu-
tyrate (Cat. No.: K401, purity 97%) were from Sigma. SF 
6847 and atpenin A5 were from Enzo Life Sciences (ELS 
AG, Lausen, Switzerland). Carboxyatractyloside (cATR) 
was from Merck (Merck KGaA, Darmstadt, Germany). 
Mitochondrial substrate stock solutions were dissolved in 
bi-distilled water and titrated to pH 7.0 with KOH. ADP 
was purchased as a  K+ salt of the highest purity available 
(Merck) and titrated to pH 6.9.
Fig. 1  Catabolism of metabo-
lites towards succinyl-CoA. 
BCKDHC: branched-chain 
keto-acid dehydrogenase; BDH: 
β-hydroxybutyrate dehydroge-
nase; GLUD: glutamate dehy-
drogenase; GOT2: aspartate 
aminotransferase; KGDHC: 
ketoglutarate dehydrogenase 
complex; MCM: methylmalonyl 
mutase; MCEE: methylmalonyl 
racemase; NDPK: nucleoside 
diphosphokinase; PCC: propi-
onyl-CoA carboxylase; SAM: 
S-adenosylmethionine; SDH: 
succinate dehydrogenase; SDS: 
l-serine dehydratase/l-threonine 
deaminase; SUCL: succinate-
coA ligase. Dashed arrows 
imply multiple steps which 
may occur inside or outside the 
mitochondrial matrix. Entrance 
of 2-KB into the matrix likely 
occurs through the mitochon-
drial pyruvate carrier (depicted 





Catabolism of Metabolites Towards Succinyl‑CoA
As shown in Fig. 1, a number of metabolites converge 
to succinyl-CoA such as glutamine, threonine, serine, 
methionine, valine, isoleucine, thymine, cholesterol and of 
course others originating upstream from α-ketoglutarate. 
Dashed arrows imply multiple steps occurring in either 
inside or outside the mitochondrial matrix. Catabolism 
of threonine, serine and methionine lead to 2-KB gen-
eration which would enter the mitochondrial matrix and 
get converted to propionyl-CoA by the branched-chain 
keto-acid dehydrogenase complex (BCKDHC), and then 
subsequently to d-methylmalonyl-CoA by propionyl-CoA 
carboxylase (PCC), consuming ATP. In turn, d-methylmal-
onyl-CoA racemizes to l-methylmalonyl-CoA by meth-
ylmalonyl-CoA epimerase (MCEE) and then isomerizes 
to succinyl-CoA by methylmalonyl-CoA mutase (MCM), 
a  B12-dependent enzyme. The aforementioned enzymes 
reside inside the mitochondrial matrix, and since they pro-
cess 2-KB it means that this metabolite traverses the inner 
mitochondrial membrane. To date, a 2-KB-specific carrier 
has not been identified, though it is known to compete for 
pyruvate transport through the mitochondrial pyruvate car-
rier [12–14] and probably the newly identified choline car-
rier [15, 16]. The reaction catalyzed by β-hydroxybutyrate 
dehydrogenase (BDH) is also shown, demonstrating the 
competition between this enzyme complex and KGDHC 
for  NAD+, in the presence of excess β-hydroxybutyrate. 
This phenomenon is exploited in our experimental settings 
in order to titrate the contribution of KGDHC yielding 
a-ketoglutarate in mitochondria with an inhibited respira-
tory chain for the purpose of mSLP. From the above meta-
bolic considerations, we set to investigate if—and to what 
extent—2-KB serves as a fuel for mitochondria, and if so, 
does it impact on mSLP.
2‑KB Supports Generation of ΔΨm in Isolated Liver 
and Brain Mitochondria by Generating Both NADH 
and  FADH2
As shown in Figs.  2 and 3 for liver and brain mito-
chondria, respectively, addition of seven 0.5 mM 2-KB 
pulses to mitochondria totaling 3.5 mM (panel Figs. 2a, 
3a) conferred a moderate decrease in safranine O fluo-
rescence implying development of ΔΨm. In liver mito-
chondria, ΔΨm was afterwards becoming gradually lost, 
as opposed to ΔΨm in brain mitochondria that remained 
stable. Subsequent addition of succinate (succ, 5 mM) led 
to maximum polarization. Further addition of the complex 
I inhibitor rotenone (rot, 1 µM) yielded no (liver mitochon-
dria) or a very small depolarization implying intact opera-
tion of complexes III and IV. At the end of the experiment 
the uncoupler SF 6847 (SF, 250 nM) was added in order 
to achieve a complete loss of ΔΨm indicating maximum 
safranine O fluorescence. However, addition of rotenone 
(Figs. 2b, 3b for liver and brain, respectively), or the com-
plex II inhibitor atpenin (atpn, 1 µM, Figs. 2c, 3c for liver 
and brain, respectively) or the dehydrogenases inhibitor 
arsenite  (H3AsO3 1 mM, Figs. 2d, 3d for liver and brain, 
respectively) abolished the effect of 2-KB conferring ΔΨm 
to mitochondria (with the exception of atpenin in brain 
mitochondria, where a mild decrease in safranine O fluo-
rescence was observed upon addition of 2-KB, Fig. 3c). 
As expected, subsequent addition of succinate (succ) led 
to development of ΔΨm if mitochondria were challenged 
by rotenone or arsenite, but not atpenin. Note that prior to 
the addition of any substrates liver mitochondria exhibit 
an initial, transient polarization which is attributed to con-
sumption of endogenous substrates, most likely acyl car-
nitines. This transient depolarization proceeds to a com-
plete loss of ΔΨm within ~ 1 h. From the above results 
Fig. 2  2-KB as a metabolic fuel in mouse liver mitochondria. Recon-
structed time courses of safranine O signal in isolated mouse liver 
mitochondria. The effect of 2-KB pulses (indicated by arrows signi-
fying 0.5 mM each, thus a total of 3.5 mM 2-KB added) is shown. 
Whenever indicated, succinate (5 mM) or rotenone (1 µM) or atpenin 
(atpn 1 µM), or arsenite  (H3AsO3, 1 mM) was added. At the end of 
each experiment 250  nM SF 6847 was added to achieve complete 
depolarization (an increase in safranine O fluorescence signal implies 
depolarization). Wherever single graphs are presented, they are repre-
sentative of at least 4 independent experiments
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we deduced that 2-KB affords ΔΨm to mitochondria by 
mechanisms involving both complex I (fueled by NADH, 
some originating from BCKDHC, an arsenite-sensitive 
enzyme complex) and complex II (fueled by  FADH2).
2‑KB Abolishes mSLP Conferred by Glutamate 
or Pyruvate
mSLP was addressed by interrogating the directionality of 
the ANT in mitochondria with an inhibited respiratory chain 
[3], isolated from mouse liver (Fig. 4a, b) or brain (Fig. 4c, 
d). The method is based on the electrogenic character of the 
ANT, as described in [3]; briefly, abolition of a “forward-
operating” ANT by carboxyatractyloside leads to a depo-
larization, while abolition of a reverse-operating ANT leads 
to repolarization. As shown in Fig. 4, mitochondria were 
added where indicated by the closed circles and safranine 
O fluorescence was recorded reflecting ΔΨm. ADP (2 mM) 
was added where indicated, initiating respiration and caus-
ing a mild depolarization due to forward ANT and  Fo–F1 
ATP synthase operation. Subsequently, oxidative phospho-
rylation was halted by inhibiting complex I with rotenone 
(rot). This led to a further loss of ΔΨm; ΔΨm was now 
maintained by a reverse-function of  Fo–F1 ATP synthase. 
Mindful of the directional synchrony of ANT with SUCL 
reaction [4], Inhibition of the ANT by carboxyatractyloside 
hints on the presence of mSLP: repolarization implies that 
SUCL operates towards ATP (or GTP) formation thus sup-
porting mSLP, while cATR-induced depolarization means 
that SUCL was hydrolyzing ATP (or GTP). Substrates were 
either glutamate and malate (5 mM each) or glutamate and 
malate and 10 mM β-hydroxybutyrate (β-OH) (Fig. 4a, c) or 
pyruvate and malate (5 mM each) as indicated in the legends 
of Fig. 4. Dose-dependent addition of 2-KB (0.5, 2 or 5 mM) 
converted the cATR-induced changes in safranine O fluo-
rescence from a repolarization to a depolarization, imply-
ing dose-dependent inhibition of mSLP by 2-KB (which 
was complete at 5 mM, or 2 mM if β-hydroxybutyrate was 
also present). This concentration range of 2-KB was chosen 
for interrogating mSLP mindful of that used in Figs. 2, 3 
verifying catabolism of this metabolite. At the end of each 
experiment, the uncoupler SF 6847 SF, 250 nM was added 
to achieve a completely depolarized state.
Fig. 3  2-KB as a metabolic fuel in mouse brain mitochondria. Recon-
structed time courses of safranine O signal in isolated mouse brain 
mitochondria. The effect of 2-KB pulses (indicated by arrows signi-
fying 0.5 mM each, thus a total of 3.5 mM 2-KB added) is shown. 
Whenever indicated, succinate (5 mM) or rotenone (1 µM) or atpenin 
(atpn 1 µM), or arsenite  (H3AsO3, 1 mM) was added. At the end of 
each experiment 250  nM SF 6847 was added to achieve complete 
depolarization (an increase in safranine O fluorescence signal implies 
depolarization). Wherever single graphs are presented, they are repre-
sentative of at least 4 independent experiments
Fig. 4  2-KB abolishes mSLP. Reconstructed time courses of safra-
nine O signal in isolated mouse liver (a, b), or brain (c, d) mitochon-
dria. Mitochondria were added where indicated by the closed circles. 
ADP (2 mM) was added where indicated. The effect of cATR (2 µM) 
on ΔΨm treated with rotenone (rot, 1 µM) in the absence or dose-
dependent presence of 2-KB as indicated in the legends is shown. 
Control traces are shown in black. At the end of each experiment 
250 nM SF 6847 was added to achieve complete depolarization (an 
increase in safranine O fluorescence signal implies depolarization). 
Wherever single graphs are presented, they are representative of at 




The most important observation of the present work is the 
abolition of mSLP by 2-KB in isolated mitochondria with 
an inhibited respiratory chain. This is likely attributed to 
ATP expenditure by PCC, even though 2-KB supports suc-
cinate-CoA ligase by providing succinyl-CoA. As a word 
of caution though, the effect of BCKDHC stealing  NAD+ 
from KGDHC (when glutamate and malate were the main 
fuels) could also contribute to abrogation of mSLP. The 
decrease in  NAD+ provision to KGDHC with the aim of 
diminishing mSLP is the strategy followed by including 
β-hydroxybutyrate in the media (supporting NADH gen-
eration by β-hydroxybutyrate dehydrogenase) relying on 
the fact that KGDHC activity is important for mSLP [7]. 
Provision of  NAD+ to KGDHC in the absence of oxidative 
phosphorylation occurs through mitochondrially-localized 
diaphorases, [17] such as mitochondrially-localized NQO1 
[18]. The effect of 2-KB inhibiting pyruvate oxidation has 
been published before [19], albeit this was only observed 
at very high 2-KB concentrations (20  mM). This was 
attributed to a weak inhibitory action of 2-KB on the pyru-
vate dehydrogenase complex [20, 21].
Our work identifies 2-KB (or metabolites converging 
towards this molecule) as abrogating mSLP in a physi-
ological manner. In human neutrophils, value ranges of 
0.01–0.07 fmol/cell have been reported [22]; mindful 
that the volume of a human neutrophil is ~ 299 µm3 [23], 
2-KB cytosolic concentration must be 0.033–0.232 mM. In 
blood plasma and urine, 2-KB concentration is < 0.01 mM 
but can be elevated ten- or hundred-fold in certain disease 
states [24–26], thus, the flux of 2-KB production by sev-
eral metabolites may indeed reach a threshold upon which 
mSLP is affected. This can be exploited in a number of 
metabolic settings in order to interrogate mSLP as part 
of the citric acid cycle [27], further benefitted by it being 
membrane-permeable. However, it must be emphasized 
that 2-KB is also a substrate for lactate dehydrogenase 
being converted to α-hydroxybutyrate [28], thus, the effect 
of 2-KB in whole cells or tissues may not only be attrib-
uted to the mechanisms outlined in the present study. By 
the same token, the effects of 2-KB described in [28] could 
be partially ascribed to its ability of negating mSLP.
Finally, since the catabolism of other metabolites con-
verging to succinyl-CoA (except those originating from 
α-Kg) besides threonine, serine and methionine also 
require expenditure of one (such as in case of valine, iso-
leucine, thymine) or two (such as with cholesterol) mol-
ecules of ATP, it is expected that they will also lead to 
abolition of mSLP. The effect of catabolism of these latter 
metabolites on mitochondrial ATP output with a dysfunc-
tional respiratory chain is currently under investigation. 
Relevant to this, it is important to emphasize that although 
ATP production mediated by succinyl-CoA ligase is small 
compared to that produced by oxidative phosphorylation, 
mSLP assumes a critical role in preventing anoxic mito-
chondria from becoming cytosolic ATP consumers, avoid-
ing straining of glycolytic ATP reserves [3].
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